T. Rowe Price Investment Management Inc. Acquires 467,301 Shares of Oscar Health, Inc. $OSCR

Key Points

• T. Rowe Price Investment Management Inc. increased its stake in Oscar Health by 4.1% in Q1, acquiring an additional 467,301 shares, bringing their total holdings to approximately $155 million.
• Oscar Health's stock is currently trading down 8.4% at around $15.24 with a market cap of $3.94 billion and a negative P/E ratio of –18.81.
• Recent analyst evaluations have downgraded Oscar Health, with several firms setting a consensus price target of $12.07 and issuing sell or hold ratings.

T. Rowe Price Investment Management Inc. grew its holdings in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 4.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,826,245 shares of the company's stock after buying an additional 467,301 shares during the period. T. Rowe Price Investment Management Inc. owned 4.72% of Oscar Health worth $155,043,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. Southeastern Asset Management Inc. TN lifted its holdings in Oscar Health by 52.2% during the 4th quarter. Southeastern Asset Management Inc. TN now owns 3,131,084 shares of the company's stock valued at $42,082,000 after purchasing an additional 1,073,359 shares during the last quarter. Jacobs Levy Equity Management Inc. raised its position in shares of Oscar Health by 37.8% in the fourth quarter. Jacobs Levy Equity Management Inc. now owns 1,741,306 shares of the company's stock valued at $23,403,000 after purchasing an additional 477,634 shares during the period. Man Group plc lifted its stake in shares of Oscar Health by 344.8% during the 4th quarter. Man Group plc now owns 1,813,216 shares of the company's stock worth $24,370,000 after buying an additional 1,405,554 shares during the last quarter. Victory Capital Management Inc. lifted its stake in shares of Oscar Health by 23.8% during the 1st quarter. Victory Capital Management Inc. now owns 285,997 shares of the company's stock worth $3,749,000 after buying an additional 54,938 shares during the last quarter. Finally, Toronto Dominion Bank bought a new stake in shares of Oscar Health during the 4th quarter worth about $1,008,000. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Trading Down 8.4%

Shares of NYSE:OSCR opened at $15.2370 on Thursday. The company has a market capitalization of $3.94 billion, a P/E ratio of -18.81 and a beta of 1.86. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.86 and a quick ratio of 0.86. The business's 50 day simple moving average is $16.04 and its 200 day simple moving average is $14.80.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, beating the consensus estimate of ($0.90) by $0.01. The firm had revenue of $2.86 billion during the quarter, compared to analysts' expectations of $2.88 billion. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The company's quarterly revenue was up 29.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.20 EPS. On average, research analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms have weighed in on OSCR. Raymond James Financial cut shares of Oscar Health from an "outperform" rating to a "market perform" rating in a report on Tuesday, June 24th. UBS Group reaffirmed a "sell" rating and issued a $11.00 target price (down previously from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Piper Sandler lowered their target price on Oscar Health from $14.00 to $13.00 and set a "neutral" rating on the stock in a research note on Thursday, August 14th. Wells Fargo & Company cut Oscar Health from an "equal weight" rating to an "underweight" rating and dropped their price target for the stock from $16.00 to $10.00 in a report on Friday, July 11th. Finally, Wall Street Zen lowered Oscar Health from a "hold" rating to a "sell" rating in a report on Saturday, August 9th. Four investment analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Strong Sell" and an average price target of $12.07.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.